No USFDA approval for Merck cough drug Gefapixant ruchika25 Jan 2022 7:17 AM GMTNew Delhi: Merck & Co said on Monday the U.S. Food and Drug Administration declined to approve its experimental drug for the treatment of...
Strides Pharma, Medicines Patent Pool ink pact to commercialize molnupiravir for global markets ruchika24 Jan 2022 3:30 AM GMTBengaluru: Strides Pharma Science Limited, a global pharmaceutical company, has recently announced its partnership with Medicines Patent Pool (MPP) to...
Merck to supply 3 million doses of molupiravir to UNICEF Medical Dialogues Team20 Jan 2022 12:32 PM GMT Merck , known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced the signing of a long-term supply agreement...
Merck COVID pill Molnupiravir likely to get WHO recommendation in February ruchika15 Jan 2022 7:30 AM GMTNew Delhi: The World Health Organization (WHO) is currently reviewing Merck's COVID-19 antiviral oral pill molnupiravir and a recommendation will likel...
Dr Reddys to launch anti-COVID drug Molnupiravir under brand name Molflu at Rs 35 per capsule Medical Dialogues Bureau5 Jan 2022 10:23 AM GMT'Molflu (Molnupiravir) is expected to be available from early next week in pharmacies throughout the country with particular focus on states with high ...
Pfizer to supply more 10 million courses of COVID pills to US Medical Dialogues Bureau5 Jan 2022 3:30 AM GMT'These pills will be delivered in the coming months and have been shown to dramatically decrease hospitalization and death from COVID19,' the White...
Can DCGI approved Molnupiravir bolster India's fight against COVID? Farhat Nasim3 Jan 2022 6:15 PM GMTNew Delhi: As countries prepare themselves to fight a possible 'next wave'. The new variant – Omicron has been making headline and a surge in Covid-19 ...
Belgium to buy courses of Pfizer, Merck COVID pills ruchika3 Jan 2022 3:30 AM GMTBrussels: Belgium has agreed to buy 10,000 courses each of the COVID-19 antiviral oral treatments developed by Pfizer and Merck & CO, a spokes...
13 pharma majors to launch anti-COVID drug Molnupiravir Medical Dialogues Team1 Jan 2022 2:06 PM GMTNew Delhi: Thirteen Indian pharmaceutical companies, including Torrent, Cipla, Sun Pharma, Dr Reddy's, Natco, Mylan, Hetero, Optimus will be manufactur...
Health Bulletin 30/December/2021 Roshni Dhar30 Dec 2021 12:29 PM GMTHere are Top health stories of the dayNiti Aayog Releases Health Index NEET PG Impasse Continues, More Doctors Join Strike MBBS, BDS Admissions 20...
Merck, Eisai get Japanese nod for cancer cocktail drug Keytruda, Lenvima ruchika30 Dec 2021 6:52 AM GMTKenilworth: Merck, known as MSD outside the United States and Canada, and Eisai have announced that the Japanese Ministry of Health, Labour and Welfare...
Cipla bags DCGI nod for COVID-19 oral antiviral, all set to launch Cipmolnu in India ruchika28 Dec 2021 9:30 AM GMTMolnupiravir is an oral anti-viral that inhibits the replication of multiple RNA viruses including SARS-CoV-2.
